Ernest Kissi Kontor

Ernest Kissi Kontor

Auto-generated profile, based on publicly available information

Ernest Kissi Kontor

Department of Theoretical and Applied Biology, College of Science, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2025 in Journal of Sickle Cell Disease
Verified
Journal Article
Open access
FUFrancis Abeku Ussher
Francis Abeku Ussher
ELEdwin Ferguson Laing
Edwin Ferguson Laing
AAAlex Bismark Atta-Owusu
Alex Bismark Atta-Owusu
EKErnest Kissi Kontor
Ernest Kissi Kontor
Nityanand JainNityanand Jain
Nityanand Jain
RNRobert Amadu Ngala
Robert Amadu Ngala
Objectives: Sickle cell anemia (SCA) is a severe form of sickle cell disease (SCD). Given the rising global disease burden and the unpredictable clinical outcomes, there is a need for development of reliable methods to predict disease severity. Methods: Our study involved 481 participants, including 356 SCA patients and 125 healthy controls, who reported at the Korle-Bu Teaching Hospital, Ghana. Using a mixed-methods approach, we performed a biomarker identification analysis followed by assessment of several machine learning (ML) models to predict the severity of SCA. Results: Significant correlations were observed between immune cells, erythrocyte indices, and bilirubin, which highlights the chronic inflammatory state and hemolytic nature of the disease. A principal component analysis (PCA) revealed strong correlations between immune cells and erythrocyte indices with PCA1 and PCA2, indicating a significant influence of immune pathways and erythropoiesis. The all-variable model achieved an area under the receiver operating characteristics curve (AUC-ROC) of 0.98 with a 92.4% predictive accuracy. The model identified direct and total bilirubin, reticulocyte count, hydrogen sulfide, and neutrophil count as the top five biomarkers with the highest average importance (scores >1.2). Further ML assessment for prediction of SCA severity exhibited excellent discriminating performance for the C5.0 decision tree (C5.0), Random Forest (RF), XG boost (XGB), and bagged trees (TREEBAG) models, with AUC-ROC ≥80% and area under the precision recall curve (AUC-PR) ≥85%. Conclusions: We identified key biomarkers associated with immune response, erythropoiesis, and oxidative stress that could serve as surrogate endpoints in clinical trials.

6 June 2025 in Women's Health
Verified
Journal Article
Open access
JBJoyce Emakayor Bening
Joyce Emakayor Bening
FDFelix Darko
Felix Darko
RARichard Anterkyi
Richard Anterkyi
VNVera Korkor Narh
Vera Korkor Narh
NPNana Yaa Agyeman Prempeh
Nana Yaa Agyeman Prempeh
MNMichael Ntim
Michael Ntim
Background: Postpartum depression is a significant public health challenge. Understanding the predictors of postpartum depression can inform targeted interventions and support systems for new mothers. Objectives: To identify and quantify sociodemographic and obstetric predictors of postpartum depression among mothers in Kumasi, Ghana. Design: A cross-sectional multicenter prospective study. Methods: A total of 502 postpartum mothers from five hospitals were included. Bayesian logistic regression analysis was used to assess model uncertainty and complex interactions between sociodemographic, economic, and obstetric factors on postpartum depression. Results: The pooled prevalence of postpartum depression was 25% (range 13% to 31%). Education attainment [coefficient = −0.43, 95% credible interval: −0.57 to −0.29, (adjusted odds ratio (aOR) = 0.65] and economic support from multiple earning members (coefficient = −0.28, 95% credible interval: −0.33 to −0.22, aOR = 0.75) substantially reduced the likelihood of postpartum depression. Being a single mother (coefficient = 0.34, 95% credible interval: 0.24 to 0.44, aOR = 1.40) increased the risk of postpartum depression. Planned pregnancies (coefficient = −0.25, 95% credible interval: −0.28 to −0.21, aOR = 0.78), doing physical exercise (coefficient = −0.26, 95% credible interval: −0.30 to −0.23, aOR = 0.77), and exclusive breastfeeding (coefficient = −0.23, 95% credible interval: −0.28 to −0.19, aOR = 0.79) were protective factors for postpartum depression. On the other hand, cesarean sections (coefficient = 0.34, 95% credible interval: 0.24 to 0.43, aOR = 1.40) and spontaneous vaginal deliveries (coefficient = 0.56, 95% credible interval: 0.47 to 0.65, aOR = 1.75) increased the risk of postpartum depression. Conclusion: Our findings emphasize the importance of identifying modifiable predictors of postpartum depression, including sociodemographic, economic, and obstetrical factors, in Kumasi, Ghana. Interventions addressing these factors, such as financial support programs, maternal education, and physician training, may significantly reduce the regional burden. Policies tailored to low-resource contexts and exhibiting local cultural sensitivity are needed for enhancing maternal–child health outcomes in Ghana and comparable regions.

1 January 2024 in Pain Research and Management
Verified
Journal Article
Open access
EKErnest Kissi Kontor
Ernest Kissi Kontor
CWCatherine Wellan
Catherine Wellan
HMHafiz Mohammad Maaz
Hafiz Mohammad Maaz
DMDaha Garba Muhammad
Daha Garba Muhammad
Almonzer Al-QiamiAlmonzer Al-Qiami
Almonzer Al-Qiami
Nityanand JainNityanand Jain
Nityanand Jain
Background: Neuropathic pain (NP) is a chronic condition caused by abnormal neuronal excitability in the nervous system. Current treatments for NP are often ineffective or poorly tolerated. Hence, we reviewed the efficacy and safety of novel drugs or devices that target neuronal excitability in NP patients compared with placebo, sham, or usual care interventions.Methods: Six databases were searched for parallel randomized controlled trials (RCTs) reporting novel devices (rTMS, SCS, and TENS) or drugs (EMA401, capsaicin 8% patch, and Sativex) for NP. Data were extracted and quality was assessed using the ROB2 tool. The random‐effects inverse variance method was used for analysis.Results: In our review of 30 RCTs with 4251 participants, device‐based interventions were found to be more effective in reducing pain scores than control interventions (SMD = −1.27, 95% CI: −1.92 to −0.62). However, high heterogeneity was seen (p < 0.01, I2 = 91%), attributable to the etiology of NP (R2 = 58.84%) and year of publication (R2 = 49.49%). Funding source and type of control comparator were ruled out as cause of heterogeneity. Although drug interventions did not differ from placebo interventions in absolute pain reduction (SMD = −1.21, 95% CI: −3.55 to 1.13), when comparing relative change in pain intensity from baseline, drug interventions were found to be effective (SMD = 0.29, 95% CI: 0.04–0.55). Asymmetry in the funnel plot was visualized, suggesting publication bias. Certainty of evidence was very low according to GRADE assessment.Conclusions: Our review indicates that device‐based interventions are more effective than control interventions in reducing pain intensity in NP. Nevertheless, available evidence is limited due to heterogeneity and publication bias, prompting the need for more high‐quality RCTs to confirm the efficacy and safety of these interventions.

4 March 2025 in Hemoglobin
Verified
Journal Article
Closed access
FUFrancis Abeku Ussher
Francis Abeku Ussher
ELEdwin Ferguson Laing
Edwin Ferguson Laing
EKErnest Kissi Kontor
Ernest Kissi Kontor
AAAlex Bismark Atta-Owusu
Alex Bismark Atta-Owusu
Nityanand JainNityanand Jain
Nityanand Jain
SAShadrach Coffie Asiedu
Shadrach Coffie Asiedu
Sickle cell disease (SCD) is a genetic disorder with a diverse spectrum of clinical presentation, often determined by inherited βS gene haplotypes. Ghana, a country with a significant SCD burden, lacks population haplotype frequency data, hindering anthropological, genetic, and clinical understanding and management of the disease. A prospective sample of 191 SCD patients (sickle cell anemia; homozygous HbSS) was recruited at the Korle-Bu Teaching Hospital, Accra. Identification of βS gene haplotypes was performed using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. Hematological tests were performed using routine laboratory procedures. Kruskal-Wallis ANOVA with Dunn post-hoc was used to compare the hematological parameters. Multinomial probability models were used to compare the frequencies of the observed haplotypes with those reported in other African countries. The Atypical haplotype was disproportionately prevalent (58%), followed by the Bantu/CAR (20%) and Benin (10%) haplotypes. Significant differences were observed between the haplotypes in lymphocyte count, platelet count, sodium and potassium levels (P < 0.001). In addition, disease severity varied significantly between haplotypes (P = 0.010), with notable differences between the Atypical and Bantu/CAR haplotypes (PFDR = 0.020). Multinomial probability testing revealed a substantial deviation from the expected haplotype distribution, highlighting significant differences in haplotype frequencies between Ghana and other African countries. The Wright-Fisher model showed that the variation in Arab-Indian haplotype frequency reached zero by the 100th generation. Our findings highlight the need to study haplotype composition in Ghana to identify population-specific risk factors and tailor public health interventions to better manage patient needs.

12 May 2025 in eLife preprints
Verified
Preprint
Open access
PDF file
ABAugustina Badu-Peprah
Augustina Badu-Peprah
EKErnest Kissi Kontor
Ernest Kissi Kontor
ABAdu-Gyamfi Benjamin
Adu-Gyamfi Benjamin
JKJessica Kumah
Jessica Kumah
AEAkosua Aya Essuman
Akosua Aya Essuman
Nityanand JainNityanand Jain
Nityanand Jain
Background Breast cancer associated mortality in Africa remains high due to poor survival rates, varying widely across countries. Despite medical advancements, barriers like limited access to early detection and treatment persist. This meta-analysis offers a crucial update on 5-year survival trends and influencing factors across continental Africa. Methods A systematic search of four biomedical databases and citation searching identified 79 articles from 22 African countries, analyzing 27,559 patients (97% female). A random-effects model was used to estimate the 5-year survival rate with subgroup analyses. Publication bias was assessed using Egger’s test and funnel plots. Results Pooled overall 5-year breast cancer survival in Africa averaged 48% (95% CI: 43-53%) with high statistical heterogeneity (I² = 98%). Survival was highest in Northern Africa (64%; 95% CI: 59-69%) and lowest in Western Africa (32%; 95% CI: 23-42%). Males (51%; 95% CI: 36-65%) had marginally higher survival than females (48%; 95% CI: 42-54%). Socioeconomic indices were positively associated with better outcomes. Publication bias, adjusted by the trim-and-fill method, raised survival to 62% (95% CI: 55-67%). A country-wise comparison with 2018 estimates suggests a declining survival tendency, with WHO AFRO countries reporting the poorest estimates among other WHO regions. Despite regional differences, survival trends seem to have plateaued near 48-49% level continent-wide since the early 2010s. Conclusions Our findings reveal marked regional disparities in survival rates across Africa, underscoring the urgent need for targeted healthcare interventions. Strengthening healthcare systems, ensuring universal access, and driving socioeconomic progress are vital to improving survival outcomes.

24 June 2025 in Clinical Medicine Insights: Cardiology
Verified
Journal Article
Open access
DNDang Nguyen
Dang Nguyen
RSRyan Shargo
Ryan Shargo
Nityanand JainNityanand Jain
Nityanand Jain
YQYusuf Qureshi
Yusuf Qureshi
LSLovepriya Suthaharan
Lovepriya Suthaharan
LDLindy G. Davidson
Lindy G. Davidson
Background: Globally, hypertension rates are rising, particularly in low-income nations where access to healthcare and education remains limited. In the Dominican Republic, marginalized Haitian migrant communities, known as Bateyes, face disproportionate burdens. However, limited information exists on their understanding of hypertension and related health risks. This program-based evaluation aimed to explore community knowledge as part of ongoing outreach efforts. Methods: We conducted a descriptive analysis of responses from 379 adults across three Bateyes in the Puerto Plata region. Participants completed a 15-item hypertension knowledge questionnaire during a routine mobile medical screening program (December 2022-January 2023) coordinated by the Kerolle Initiative. Hierarchical clustering was used to identify knowledge patterns and explore associations with community differences and systolic blood pressure (SBP) levels. Results: Average BP values were 133/84 mmHg for males and 125/84 mmHg for females, with 27% of respondents meeting the clinical threshold for hypertension. Knowledge levels varied with 44% of participants having insufficient knowledge, and only one participant demonstrating adequate knowledge. Knowledge was associated with education level and household income. Poor awareness of basic concepts emerged as a key driver of variation across Bateyes. Cluster analysis revealed three knowledge patterns: (1) awareness shaped by lived experience of hypertension; (2) gaps due to common misconceptions; and (3) protective behaviors likely influenced by broader public messaging. Conclusion: Findings from our educational outreach program evaluation suggest variable hypertension awareness across Batey communities. These observations highlight key areas for tailoring future community-centered health education efforts to the local needs of Bateyes.